Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence

Targeting peroxisome proliferator-activated receptors (PPARs) has received increasing interest as a potential strategy to treat substance use disorders due to the localization of PPARs in addiction-related brain regions and the ability of PPAR ligands to modulate dopamine neurotransmission. Robust e...

Descripción completa

Detalles Bibliográficos
Autores principales: Matheson, Justin, Le Foll, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291117/
https://www.ncbi.nlm.nih.gov/pubmed/32408505
http://dx.doi.org/10.3390/cells9051196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291117/
https://www.ncbi.nlm.nih.gov/pubmed/32408505
http://dx.doi.org/10.3390/cells9051196

Ejemplares similares